CCL5 Antikörper (Middle Region)
Kurzübersicht für CCL5 Antikörper (Middle Region) (ABIN925838)
Target
Alle CCL5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - Middle Region
 - 
                                            
Kreuzreaktivität
 - Ratte (Rattus), Hund, Huhn, Schwein, Human, Rind (Kuh)
 - 
                                            
Immunogen
 - CCL5 antibody was raised in rabbit using the middle region of CCL5 as the immunogen
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. - 
                                            
Kommentare
 - 
                        
CCL5 Blocking Peptide, (ABIN936073), is also available for use as a blocking control in assays to test for specificity of this CCL5 antibody
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Konzentration
 - Lot specific
 - 
                                            
Buffer
 - Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
 - 
                                            
Handhabung
 - Avoid repeated freeze/thaw cycles.
 - 
                                            
Lagerung
 - 4 °C/-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
 - 
                                            
 - 
    
- CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
 - 
                                            
Andere Bezeichnung
 - CCL5
 - 
                                            
Hintergrund
 - Recently, it has been shown that genetic polymorphisms can result in diminished expression of CCL5, which results in increased susceptibility to and progression of infectious diseases. CCL5, together with Th cytokine mRNA expression, is temporally up-regulated during pneumococcal carriage. CCL5 is an essential factor for the induction and maintenance of protective pneumococcal immunity. Synonyms: Polyclonal CCL5 antibody, Anti-CCL5 antibody, Chemokine (C-C motif) ligand 5 antibody.
 - 
                                            
Pathways
 - Cellular Response to Molecule of Bacterial Origin, Regulation of G-Protein Coupled Receptor Protein Signaling, Smooth Muscle Cell Migration
 
Target
 -